Cell Death and Disease · 2022 · 41 citations · 49 references
Life SciencesCell BiologyOncologyCell SignalingNeoplasiaSignal TransductionCancer Cell SignalingCell Cycle SignalingCytokine Receptor SignalingOncogenic Signaling PathwaysExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingMapk SignalingMek InhibitionMek InhibitorsMitogen-activated Protein Kinase PathwaysMitogen-activated Protein Kinase SignalingStat3 Signaling
Esophageal squamous cell carcinoma (ESCC) is one of the world's leading causes of death, and its primary clinical therapy relies on surgical resection, chemotherapy, radiotherapy, and chemoradiotherapy. Although the genomic features and clinical significance of ESCC have been identified, the outcomes of targeted therapies are still unsatisfactory. Here, we demonstrate that mitogen-activated protein kinase (MAPK) signaling is highly activated and associated with poor prognosis in patients with ESCC. Mitogen-activated protein kinase kinase (MEK) inhibitors efficiently blocked the phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) in ESCC, while signal transducer and activator of transcription 3 (STAT3) signaling was rapidly activated. Combined STAT3 inhibition prevented the emergence of resistance and enhanced MEK inhibitor-induced cell cycle arrest and senescence in vitro and in vivo. Mechanistic studies revealed that the suppressor of cytokine signaling 3 (SOCS3) was downregulated, resulting in an increase in STAT3 phosphorylation in MEK-inhibited cells. Furthermore, chromatin immunoprecipitation showed that ELK1, which was activated by MEK/ERK signaling, induced SOCS3 transcription. These data suggest that the development of combined MEK and STAT3 inhibition could be a useful strategy in ESCC targeted therapy.
49
Expanded encyclopaedias of DNA elements in the human and mouse genomes
Federico Abascal, Reyes Acosta, Nicholas J. Addleman et al. · Nature · 2020 · 2.6K citations · Full text
Global incidence of oesophageal cancer by histological subtype in 2012
Melina Arnold, Isabelle Soerjomataram, Jacques Ferlay et al. · Gut · 2014 · 1.5K citations · Full text
Identification of genomic alterations in oesophageal squamous cell cancer
Yongmei Song, Lin Li, Yunwei Ou et al. · Nature · 2014 · 1.1K citations